| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.32 | 3e-07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 5e-07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.33 | 6e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |